on 1 Dec 2017
Last Applicant/ Owned by
Sigrid Therapeutics AB
57 Birger Jarlsgatan
Stockholm, , 113 56
Serial Number
UK00917548314 filed on 1st Dec 2017
Registration Number
UK00917548314 registered on
10th Aug 2018
Correspondent Information
Potter Clarkson LLP
Chapel Quarter, Mount Street
Nottingham,
NG1 6HQ
Dietetic preparations adapted for medical use; dietetic substances adapted for medical use; pharmaceuticals and natural remedies; preparations for use in naturopathy; nutritional supplements; chemical preparations for medical purposes; pharmaceutical preparations; chemico-pharmaceutical preparations; dietary and nutritional supplements; health food supplements for persons with special dietary requirements; chemical preparations for pharmaceutical purposes; pharmaceutical preparations and substances for glycemic control; pharmaceutical preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietetic preparations and substances for glycemic control; dietetic preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietary and nutritional supplements for glycemic control; dietary and nutritional supplements for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in glycemic control; tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations and substances, dietary and nutritional substances, tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, colitis; pharmaceutical preparations and substances, dietary and nutritional substances, tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of intestinal injury or inflammation, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients; not including products primarily for use in the treatment of angina pectoris and high blood pressure.
Surgical and medical devices; capsulated medical devices; medical devices for the treatment and/or prevention of obesity and being overweight and their related diseases, and/or for use in weight control; medical devices for prediabetes, diabetes and glycaemic control, and for the improvement of overall metabolic health; medical devices for use in the prevention and treatment of prediabetes and diabetes; orally administered medical devices; surgical and medical devices, capsulated devices and orally administered medical devices all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, intestinal injury or inflammation, colitis, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients.
UK00917548314
Word
Individual